FIELD: immunology, cell therapy.
SUBSTANCE: claimed composition contains heat shock protein of HSP family or fragment thereof and tumor-specific peptide selected from group containing MAGE-A1, -A2, -A3, gp100, HER2/NEU, EGFRvIII or fragment thereof non-covalently bound to said protein, wherein non-covalent bond is provided by preliminary incubation of components under physiological conditions with adenosine diphosphate. As heat shock protein composition contains protein selected from group containing DnaK from M. tuberculosis, M. bovis or E. coli or human HSP 70 protein. Tumor-specific peptide fragments are described in table represented in description. Additionally composition contains immunomodulator selected from group containing INFα, INFγ, TNFα, IL-2, -4, -6 or combination thereof and pharmaceutical carrier. Also disclosed are cell preparation which represents isolated and washed dendrite leucocytes activated by incubation with new composition as well as method for tumor immunotherapy or immunoprophylaxis by parenteral administration of composition or cell preparation in effective dose.
EFFECT: new antitumor preparation of improved effectiveness.
8 cl, 1 tbl, 8 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
| VACCINE COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF TUMOR DISEASES, RECOMBINANT PLASMID DNA PROVIDING HYBRID PROTEIN SYNTHESIS AND METHOD FOR PRODUCTION THEREOF | 2006 |
|
RU2316342C1 |
| METHOD FOR PRODUCTION OF PROTEIN PREPARATION BELONGING TO STRESS GENUS AND HSP70 PROTEIN PREPARATION OBTAINED BY SAID METHOD | 2005 |
|
RU2283128C1 |
| METHOD OF TREATING PATIENTS WITH SKIN CANCER WITH NEOPLASTIC PROCESSES INVOLVING SKIN TISSUE, SUCH AS MELANOMA, BASAL CELL AND SQUAMOUS CELL CARCINOMA (VERSIONS) | 2014 |
|
RU2577135C2 |
| METHOD FOR TREATMENT OF ONCOLOGY DISEASES | 2004 |
|
RU2271831C1 |
| VECTOR POLYPEPTIDE ANALOG OF TRANSFORMING GROWTH FACTOR ALPHA (TGF) FRAGMENT, ITS ANTITUMOR CONJUGATE AND PHARMACEUTICAL COMPOSITION ON CONJUGATE BASE | 2004 |
|
RU2277930C1 |
| POLYEPITOPE ANTI-TUMOUR VACCINE STRUCTURE CONTAINING EPITOPES OF TUMOR-ASSOCIATED ANTIGENS, PHARMACEUTICAL COMPOSITION AND ITS APPLICATION FOR STIMULATING SPECIFIC ANTI-TUMOR IMMUNE RESPONSE | 2016 |
|
RU2684235C2 |
| VAGINAL SUPPOSITORIES FOR TREATMENT OF CERVICAL CARCINOMA | 2008 |
|
RU2404794C2 |
| ANTITUMOR PEPTIDE PREPARATION BASED ON ALPHA-FETOPROTEIN FRAGMENT, ITS CONJUGATE, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF HORMONE-DEPENDENT TUMORS | 2005 |
|
RU2285537C1 |
| POLYPEPTIDE DISPLAYING ANALOG OF RECEPTOR-BINDING EPIDERMAL GROWTH FACTOR FRAGMENT FROM 21 TO 31 AMINO ACIDS, ITS CONJUGATE WITH DOXORUBICIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2196604C1 |
